These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37798150)

  • 21. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
    Sahara K; Tsilimigras DI; Mehta R; Moro A; Paredes AZ; Lopez-Aguiar AG; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Poultsides GA; Makris E; Cho C; Beems M; Dillhoff M; Maithel SK; Endo I; Pawlik TM
    Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascularity and Tumor Size are Significant Predictors for Recurrence after Resection of a Pancreatic Neuroendocrine Tumor.
    Yamamoto Y; Okamura Y; Uemura S; Sugiura T; Ito T; Ashida R; Kato Y; Ohgi K; Yamada M; Sasaki K; Aramaki T; Uesaka K
    Ann Surg Oncol; 2017 Aug; 24(8):2363-2370. PubMed ID: 28271173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.
    Bertani E; Fazio N; Radice D; Zardini C; Grana C; Bodei L; Funicelli L; Ferrari C; Spada F; Partelli S; Falconi M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):981-989. PubMed ID: 27613553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors.
    Du S; Ni J; Weng L; Ma F; Li S; Wang W; Sang X; Lu X; Zhong S; Mao Y
    Medicine (Baltimore); 2015 Aug; 94(34):e1429. PubMed ID: 26313798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SURGICAL TREATMENT OF METASTATIC NON—FUNCTIONING NEUROENDOCRINE TUMORS OF THE PANCREAS].
    Shkarban VP
    Klin Khir; 2016; (7):5-7. PubMed ID: 30256557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The First Case Report of Robotic Multivisceral Resection for Synchronous Liver Metastasis from Pancreatic Neuroendocrine Tumor: A Case Report and Literature Review.
    Calin ML; Sadiq A; Arevalo G; Fuentes R; Flanders VL; Gupta N; Nasri B; Singh K
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):816-824. PubMed ID: 27454160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients.
    Zheng J; Pulvirenti A; Javed AA; Michelakos T; Paniccia A; Lee KK; Ferrone CR; Wei AC; He J; Zureikat AH;
    J Am Coll Surg; 2022 Aug; 235(2):315-330. PubMed ID: 35839409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.
    Jilesen AP; van Eijck CH; in't Hof KH; van Dieren S; Gouma DJ; van Dijkum EJ
    World J Surg; 2016 Mar; 40(3):729-48. PubMed ID: 26661846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis.
    Sirtl S; Mahajan UM; Auernhammer CJ; Dziadkiewicz P; Hohmann E; Wójcik M; Kos-Kudła B; Hartleb M; Knösel T; Schirra J; Mayerle J; Schulz C; Żorniak M
    Pancreatology; 2022 Jun; 22(5):644-650. PubMed ID: 35589512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
    Ismail H; Broniszczak D; Markiewicz-Kijewska M; Ciopiński M; Teisseyre J; Kluge P; Dembowska-Bagińska B; Kościesza A; Socha P; Kaliciński P
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):e33-7. PubMed ID: 26850362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
    Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
    Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
    Gudmundsdottir H; Pery R; Graham RP; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Habermann EB; Nagorney DM; Cleary SP
    Ann Surg Oncol; 2022 Oct; 29(11):6949-6957. PubMed ID: 35731358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
    Cloyd JM; Kopecky KE; Norton JA; Kunz PL; Fisher GA; Visser BC; Dua MM; Park WG; Poultsides GA
    Surgery; 2016 Sep; 160(3):708-13. PubMed ID: 27216830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Is the Role of Lymph Node Resections in Small Islet Tumors?
    Gangi A; Ferrone CR
    Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.
    House MG; Cameron JL; Lillemoe KD; Schulick RD; Choti MA; Hansel DE; Hruban RH; Maitra A; Yeo CJ
    J Gastrointest Surg; 2006 Jan; 10(1):138-45. PubMed ID: 16368504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.